Treatment strategies for co-occurring ADHD and substance use disorders

被引:104
|
作者
Mariani, John J.
Levin, Frances R.
机构
[1] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Div Substance Abuse, New York, NY USA
来源
关键词
D O I
10.1080/10550490601082783
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Attention-deficit hyperactivity disorder (ADHD) is a common co-occurring mental disorder among patients with substance use disorders (SUD). Clinicians must be cognizant of the complicated nature of diagnosis and treatment of ADHD when comorbid with SUD. Pharmacotherapy remains the mainstay of treatment for ADHD, although complementary psychotherapeutic approaches have been developed. Psychostimulant medications are the most commonly used medications to treat ADHD, but many clinicians are reluctant to prescribe stimulants to patients with SUD. Recommendations for treatment planning and clinical management for patients with co-occurring ADHD and SUD are discussed.
引用
下载
收藏
页码:45 / 56
页数:12
相关论文
共 50 条